<DOC>
	<DOCNO>NCT02608515</DOCNO>
	<brief_summary>This non-interventional retrospective chart review study aim evaluate clinical outcome patient RRMM receive lenalidomide/dexamethasone ( Len/Dex ) treatment 1st relapse treatment pattern follow progressive disease part routine clinical practice Greece .</brief_summary>
	<brief_title>A Retrospective Chart Review Study Outcomes 2nd Line Therapy With LEn/Dex Greek Patients With R/R Multiple MyEloma Treatment PatterNs Following Progressive Disease</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<criteria>Subjects must fulfill ALL follow criterion : Subjects gender , age 18 year old Subjects must relapse refractory MM diagnosis accord IMWG EBMT criterion Subjects must initiate secondline therapy lenalidomide/dexamethasone accord approve product ' Summary Product Characteristics ( SmPC ) 01 January 2009 01 March 2014 Subjects must available medical files/records detail historical data disease course clinical management Provision sign ICF collect analyze medical data pertinent objective study For candidate subject NONE follow criterion apply : Prior malignancy ( within 3 year precede initial diagnosis MM ) Concurrent administration anticancer regimens malignancy MM time initial MM diagnosis time second relapse Subject participation interventional study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>